Literature DB >> 4280018

The protective effect of hydantoin treatment on carcinogenesis.

Y Levo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4280018     DOI： 10.1007/bf00499526

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  5 in total

Review 1.  IMMUNOLOGICAL FACTORS IN THE PROCESS OF CARCINOGENESIS.

Authors:  M BURNET
Journal:  Br Med Bull       Date:  1964-05       Impact factor: 4.291

2.  Potential hazards of hydantoin use.

Authors:  J D Easton
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

3.  Enhancement of lung adenoma formation by neonatal thymectomy in mice treated with 7,12-dimethylbenz(a)anthracene or urethan.

Authors:  N Trainin; M Linker-Israeli; M Small; L Boiato-Chen
Journal:  Int J Cancer       Date:  1967-07-15       Impact factor: 7.396

4.  Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin).

Authors:  T C Sorrell; I J Forbes; F R Burness; R H Rischbieth
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321

5.  Immunological abnormalities and hydantoins.

Authors:  P J Grob; G E Herold
Journal:  Br Med J       Date:  1972-06-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.